Finally, pharmacological inhibition of biosynthesis of the CD44 substrate hyaluronan by 4-methylumbelliferone reduced angiogenesis in an in vivo mouse model of endometriosis [165], suggesting that interference with the CD44-hyaluronan axis may represent an approach that synchronously targets multiple molecular mechanisms of endometriosis. This evidence concerns the gene CD44 and endometriosis.